2007
DOI: 10.4012/dmj.26.481
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Dose of Recombinant Human BMP-2 on Bone Formation at Palatal Sites in Young and Old Rats

Abstract: This study was designed to examine the effects of dose of recombinant human BMP-2 (rhBMP-2) on bone formation at palatal sites in 10-week-old (10w) and 70-week-old (70w) rats, when combined with a polylactate-polyglycolate copolymer/gelatine sponge (PGS).New bone formation was observed at six weeks after implantation. In the 10w rats, thickness of new bone (TNB) increased as the dosage increased from 0 μg to 4 μg, and decreased significantly as the dosage increased from 8 μg to 24 μg. In contrast, in the 70w r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
6
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 23 publications
2
6
0
Order By: Relevance
“…BMPs) which have osteogenic and osseoconductive effects (Rahn and Perren, 1970;Rahn, 1976;Allegrini et al, 2003). The osseoinductive effect of rhBMP-2 depends on the amount of cells in the region of augmentation which in turn depends on the species, the age and the vascularity of the area (Terheyden et al, 1999;Yamaji et al, 2007). Sinus-lift procedures in a sheep model are a reliable method for evaluating bone formation (Aral et al, 2008;Estaca et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…BMPs) which have osteogenic and osseoconductive effects (Rahn and Perren, 1970;Rahn, 1976;Allegrini et al, 2003). The osseoinductive effect of rhBMP-2 depends on the amount of cells in the region of augmentation which in turn depends on the species, the age and the vascularity of the area (Terheyden et al, 1999;Yamaji et al, 2007). Sinus-lift procedures in a sheep model are a reliable method for evaluating bone formation (Aral et al, 2008;Estaca et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…According to BMP‐2(100) group, the peak of its mineral content was observed at 4 weeks, whereas the mineral content of BMP‐2(50) group was maintained ascending to 12 weeks, which might suggest that the peak point was advanced as the dose of the plasmid increased. This might be because osteogenic reagents, such as BMP‐2, recruit and activate not only osteoprogenitor cells but also bone‐resorbing cells like osteoclasts 32–34. Since a fine balance probably exists between the opposing effects of osteogenic factors, it is necessary to optimize its dose, its mode of delivery, and the timing of its release to maximize osteoinductive or osteoconductive responses.…”
Section: Discussionmentioning
confidence: 99%
“…BMP2 and BMP7 homodimers were reported to accelerate bone formation efficiently. However, the use of the BMP homodimers is associated with a high cost 5,24) and potential side-effects 25) . BMP 2/7 heterodimers have been proposed to overcome the disadvantages of BMP homodimers.…”
Section: Discussionmentioning
confidence: 99%
“…Several regional bone regeneration techniques including bone tissue engineering has been reported to solve such peri-implant bone defect [1][2][3] . Bone morphogenetic proteins (BMPs) emerge as promising candidates for bone tissue engineering due to their significant effects on bone and cartilage growth 4,5) . The efficacy of BMP homodimers therapy has been proved to be successful in many animal experiments, but the wide application of BMP homodimers in the clinic is limited by the high effective dosage (e.g.…”
Section: Introductionmentioning
confidence: 99%